0009K0 — Aimed Bio Income Statement
0.000.00%
Last trade - 00:00- KR₩4tn
- KR₩3tn
- KR₩47bn
Annual income statement for Aimed Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 171 | 11,760 | 47,278 |
| Cost of Revenue | |||
| Gross Profit | -124 | 10,986 | 45,753 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 6,582 | 12,168 | 26,509 |
| Operating Profit | -6,411 | -408 | 20,769 |
| Gain / Loss on Sale of Assets | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -9,030 | -3,313 | -4,164 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -9,030 | -3,313 | 5,018 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | -9,023 | -3,304 | 5,023 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -9,023 | -3,304 | 5,023 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -141 | -51.5 | 108 |
| Dividends per Share |